Darbepoetin alfa, esrd use
Products billed under this code include Aranesp.
Payment limit per 1 MCG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J0882
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Aranesp | Amgen Inc | 55513-0002-04 | 100 | $308.10 |
| Aranesp | Amgen Inc | 55513-0003-04 | 160 | $492.96 |
| Aranesp | Amgen Inc | 55513-0004-04 | 240 | $739.44 |
| Aranesp | Amgen Inc | 55513-0005-04 | 400 | $1,232.40 |
| Aranesp | Amgen Inc | 55513-0006-01 | 200 | $616.20 |
| Aranesp | Amgen Inc | 55513-0021-04 | 160 | $492.96 |
| Aranesp | Amgen Inc | 55513-0023-04 | 240 | $739.44 |
| Aranesp | Amgen Inc | 55513-0025-04 | 400 | $1,232.40 |
| Aranesp | Amgen Inc | 55513-0027-04 | 600 | $1,848.60 |
| Aranesp | Amgen Inc | 55513-0028-01 | 200 | $616.20 |
Show all 14 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Aranesp | Amgen Inc | 55513-0032-01 | 500 | $1,540.50 |
| Aranesp | Amgen Inc | 55513-0057-04 | 100 | $308.10 |
| Aranesp | Amgen Inc | 55513-0098-04 | 40 | $123.24 |
| Aranesp | Amgen Inc | 55513-0111-01 | 300 | $924.30 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $3.081 | +$0.161 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted September 17, 2026 |
| 3Q26 | $2.92 | −$0.152 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted September 15, 2026 |
| 2Q26 | $3.072 | +$0.051 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted September 15, 2026 |
| 1Q26 | $3.021 | +$0.095 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted September 15, 2026 |
| 4Q25 | $2.926 | −$0.069 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted September 8, 2026 |
| 3Q25 | $2.995 | +$0.077 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted March 10, 2026 |
| 2Q25 | $2.918 | −$0.054 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted March 10, 2026 |
| 1Q25 | $2.972 | −$0.064 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted December 19, 2025 |
| 4Q24 | $3.036 | −$0.027 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted June 11, 2025 |
| 3Q24 | $3.063 | +$0.162 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted June 11, 2025 |
| 2Q24 | $2.901 | −$0.029 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted March 11, 2025 |
| 1Q24 | $2.93 | −$0.015 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted December 19, 2024 |
| 4Q23 | $2.945 | +$0.009 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted October 10, 2024 |
| 3Q23 | $2.936 | −$0.153 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted June 5, 2024 |
| 2Q23 | $3.089 | −$0.034 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted February 23, 2024 |
| 1Q23 | $3.123 | −$0.036 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted December 6, 2023 |
| 4Q22 | $3.159 | −$0.156 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted June 22, 2023 |
| 3Q22 | $3.315 | +$0.031 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted June 9, 2023 |
| 2Q22 | $3.284 | +$0.19 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted December 14, 2022 |
| 1Q22 | $3.094 | −$0.06 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted June 8, 2022 |
| 4Q21 | $3.154 | −$0.041 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted June 2, 2022 |
| 3Q21 | $3.195 | −$0.111 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted June 2, 2022 |
| 2Q21 | $3.306 | −$0.252 | 1 MCG | Darbepoetin alfa, esrd use | v1, posted March 1, 2022 |
| 1Q21 | $3.558 | – | 1 MCG | Darbepoetin alfa, esrd use | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023
- 2Q22: 2022-12-14_april-2022-asp-pricing-file.zipposted December 14, 2022
- 1Q22: 2022-06-08_january-2022-asp-pricing-file.zipposted June 8, 2022
- 4Q21: 2022-06-02_october-2021-asp-pricing-file.zipposted June 2, 2022
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021